Fatal Hantavirus Outbreak on Luxury Cruise Ends

This spring, what seemed like a typical stomach illness on a luxury cruise ship quickly escalated into a serious hantavirus outbreak. Initially, reports indicated common stomach bug symptoms, but as events unfolded, it turned into a global health alert, resulting in extensive quarantines for passengers on the vessel.

On Thursday, the World Health Organization announced that the outbreak had officially concluded. There were 12 confirmed cases aboard, including one probable case and three fatalities.

The declaration came after the last passenger, who had been in quarantine, tested negative for the virus, according to the health agency, part of the United Nations. This announcement marked the end of a challenging three-month period that saw scientists racing to identify the outbreak’s source, while crew and passengers found themselves isolated, and health officials worked on contact tracing and quarantine measures.

The Journey of the MV Hondius

The MV Hondius set sail on April 1, carrying 175 passengers and crew from various countries. Tragically, the first reported illness appeared just days into the trip, with the initial victim dying less than two weeks later.

The last known case of illness occurred on May 25, as noted by the W.H.O. director general. Passengers had planned to enjoy a scenic journey, stopping at remote islands across the southern Atlantic, with highlights including mainland Antarctica and the Falkland Islands.

Interestingly, many passengers were keen bird watchers interested in the local wildlife around Ushuaia, particularly a landfill known for sightings of a specific raptor. There was some early speculation that this landfill could have been the source of the virus.

After the outbreak began, as the ship made its way toward Cape Verde, it was denied entry by officials concerned that they could not manage the situation. This resulted in the ship being stranded in the Atlantic, with passengers and crew facing months of isolation.

Patient Zero and the Progression of Illness

The first patient was a 69-year-old Dutch man who began showing flu-like symptoms on April 6. Sadly, he passed away on board just days later. His wife also fell ill and died shortly thereafter in South Africa.

Following the couple’s deaths, several passengers disembarked in St. Helena, a British territory, with more cases cropping up. By April 28, a German woman exhibited severe symptoms and died on May 2 aboard the ship.

On May 3, the W.H.O. confirmed that hantavirus had infected individuals on the cruiser, attributing this to the illnesses that had been reported. By this point, seven infections were linked to the outbreak.

A Long Wait for Docking

Finally, on May 9, the Spanish government permitted theMV Hondius to dock in Tenerife, one of the Canary Islands, after nearly six weeks at sea. During a brief time on land, all remaining passengers underwent testing and disembarked.

By May 11, many passengers were either returning home or already on their way, with several, including a group of Americans, being quarantined upon arrival.

The ship arrived in Rotterdam on May 18, with strict protocols in place. A small number of passengers were placed in quarantine after thorough inspections and cleaning of the vessel.

In total, over 650 individuals who had contact with passengers were tracked, leading health officials from numerous countries to follow up with those involved.

Understanding the Hantavirus

The W.H.O. stated that the outbreak likely originated on land, not from the ship itself. They identified the strain as the Andes subtype, known to transmit between individuals in close proximity.

This strain, which caused the initial deaths, is a known concern in specific regions of Argentina, where cases appear yearly. Currently, there are no specific treatments or widely available vaccines for hantaviruses.

Yet, Dr. Tedros expressed hope for future advancements, mentioning ongoing studies across 21 countries aimed at understanding the disease better. This research could pave the way for new diagnostics, treatments, and vaccines for future outbreaks.